![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Schiff Nutrition International, Inc. | NYSE:WNI | NYSE | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.51 | 0.00 | 01:00:00 |
Delaware
|
001-14608
|
87-0563574
|
||
(State or other jurisdiction of incorporation or organization)
|
(Commission File Number)
|
(I.R.S. Employer
Identification Number)
|
||
2002 South 5070 West
Salt Lake City, Utah
|
84104-4726
|
|||
(Address of principal
executive offices)
|
(Zip Code)
|
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 9.01.
|
Financial Statements and Exhibits.
|
(a)
|
Financial Statements Of Business Acquired.
|
·
|
The audited statement of assets acquired and liabilities assumed as of December 31, 2010 for the Business Acquired and the related audited statement of revenues and direct expenses for the year ended December 31, 2010.
|
·
|
The unaudited statement of assets acquired and liabilities assumed as of March 31, 2010 for the Business Acquired and the related unaudited statements of revenues and direct expenses for the three months ended March 31, 2011 and 2010.
|
(b)
|
Pro Forma Financial Information.
|
(d)
|
Exhibits.
|
Exhibit
No.
|
Description
|
|
23.1
|
Consent of SS&G Financial Services, Inc., Certified Public Accountants.
|
|
99.1
|
Audited Financial Statements of Ganeden Biotech, Inc. Dietary Supplements Business as of and for the year ended December 31, 2010 and the Unaudited Financial Statements as of March 31, 2011, and for the three months ended March 31, 2011 and 2010, and the notes thereto.
|
|
99.2
|
Unaudited pro forma financial information of the Company and Subsidiaries as of and for the nine months ended February 28, 2011 and for the year ended May 31, 2010.
|
By:
|
/s/ JOSEPH W. BATY
|
Name: Joseph W. Baty
|
|
Title: Executive Vice President and Chief Financial Officer
|
|
Date: August 12, 2011
|
Exhibit
No.
|
Description
|
|
23.1
|
Consent of SS&G Financial Services, Inc., Certified Public Accountants.
|
|
99.1
|
Audited Financial Statements of Ganeden Biotech, Inc. Dietary Supplements Business as of and for the year ended December 31, 2010 and the Unaudited Financial Statements as of March 31, 2011, and for the three months ended March 31, 2011 and 2010, and the notes thereto.
|
|
99.2
|
Unaudited pro forma financial information of the Company and Subsidiaries as of and for the nine months ended February 28, 2011 and for the year ended May 31, 2010.
|
1 Year Schiff Nutrit Chart |
1 Month Schiff Nutrit Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions